Literature DB >> 15995835

Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer.

Geert M Villeirs1, Koen Van Vaerenbergh, Luc Vakaet, Samuel Bral, Filip Claus, Wilfried J De Neve, Koenraad L Verstraete, Gert O De Meerleer.   

Abstract

PURPOSE: To quantify interobserver variation of prostate and seminal vesicle delineations using CT only versus CT + MRI in consensus reading with a radiologist.
MATERIAL AND METHODS: The prostate and seminal vesicles of 13 patients treated with intensity-modulated radiotherapy for prostatic adenocarcinoma were retrospectively delineated by three radiation oncologists on CT only and on CT + MRI in consensus reading with a radiologist. The volumes and margin positions were calculated and intermodality and interobserver variations were assessed for the clinical target volume (CTV), seminal vesicles, prostate and three prostatic subdivisions (apical, middle and basal third).
RESULTS: Using CT + MRI as compared to CT alone, the mean CTV, prostate and seminal vesicle volumes significantly decreased by 6.54%, 5.21% and 10.47%, respectively. More importantly, their standard deviations significantly decreased by 63.06%, 62.65% and 44.83%, respectively. The highest level of variation was found at the prostatic apex, followed by the prostatic base and seminal vesicles.
CONCLUSION: Addition of MRI to CT in consensus reading with a radiologist results in a moderate decrease of the CTV, but an important decrease of the interobserver delineation variation, especially at the prostatic apex.

Entities:  

Mesh:

Year:  2005        PMID: 15995835     DOI: 10.1007/s00066-005-1383-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  43 in total

1.  Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy.

Authors:  I Fotina; C Lütgendorf-Caucig; M Stock; R Pötter; D Georg
Journal:  Strahlenther Onkol       Date:  2012-01-27       Impact factor: 3.621

2.  Concurrent segmentation of the prostate on MRI and CT via linked statistical shape models for radiotherapy planning.

Authors:  Najeeb Chowdhury; Robert Toth; Jonathan Chappelow; Sung Kim; Sabin Motwani; Salman Punekar; Haibo Lin; Stefan Both; Neha Vapiwala; Stephen Hahn; Anant Madabhushi
Journal:  Med Phys       Date:  2012-04       Impact factor: 4.071

3.  Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience.

Authors:  Domenico Genovesi; Giampiero Ausili Cèfaro; Annamaria Vinciguerra; Antonietta Augurio; Monica Di Tommaso; Rita Marchese; Umberto Ricardi; Andrea Riccardo Filippi; Theodore Girinsky; Katiuscia Di Biagio; Maurizio Belfiglio; Enza Barbieri; Vincenzo Valentini
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

4.  Quantitative evaluation of diffusion-weighted imaging techniques for the purposes of radiotherapy planning in the prostate.

Authors:  G P Liney; L Holloway; T M Al Harthi; M Sidhom; D Moses; E Juresic; R Rai; D J Manton
Journal:  Br J Radiol       Date:  2015-03-05       Impact factor: 3.039

5.  Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.

Authors:  Geoffrey V Martin; Thomas J Pugh; Usama Mahmood; Rajat J Kudchadker; Jihong Wang; Teresa L Bruno; Tharakeswara Bathala; Pierre Blanchard; Steven J Frank
Journal:  Brachytherapy       Date:  2017-05-10       Impact factor: 2.362

6.  Delineation of the larynx as organ at risk in radiotherapy: a contouring course within "Rete Oncologica Piemonte-Valle d'Aosta" network to reduce inter- and intraobserver variability.

Authors:  Domenico Cante; Edoardo Petrucci; Cristina Piva; Valeria Casanova Borca; Piera Sciacero; Maurizio Bertodatto; Caterina Marta; Pierfrancesco Franco; Monica Viale; Giovanni La Valle; Maria Rosa La Porta; Oscar Bertetto
Journal:  Radiol Med       Date:  2016-07-15       Impact factor: 3.469

7.  Multimodal image registration for the identification of dominant intraprostatic lesion in high-precision radiotherapy treatments.

Authors:  Delia Ciardo; Barbara Alicja Jereczek-Fossa; Giuseppe Petralia; Giorgia Timon; Dario Zerini; Raffaella Cambria; Elena Rondi; Federica Cattani; Alessia Bazani; Rosalinda Ricotti; Maria Garioni; Davide Maestri; Giulia Marvaso; Paola Romanelli; Marco Riboldi; Guido Baroni; Roberto Orecchia
Journal:  Br J Radiol       Date:  2017-08-22       Impact factor: 3.039

8.  Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?

Authors:  L Van den Bergh; S Isebaert; M Koole; R Oyen; S Joniau; E Lerut; C M Deroose; F De Keyzer; H Van Poppel; K Haustermans
Journal:  Strahlenther Onkol       Date:  2013-09       Impact factor: 3.621

9.  Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Treatment planning, quality control, and clinical implementation.

Authors:  Katrien Vandecasteele; Wilfried De Neve; Werner De Gersem; Louke Delrue; Leen Paelinck; Amin Makar; Valérie Fonteyne; Carlos De Wagter; Geert Villeirs; Gert De Meerleer
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

10.  The impact of prostate gland dimension in genitourinary toxicity after definitive prostate cancer treatment with moderate hypofractionation and volumetric modulated arc radiation therapy.

Authors:  R Mazzola; S Fersino; A Fiorentino; F Ricchetti; N Giaj Levra; G Di Paola; G Sicignano; S Naccarato; R Ruggieri; F Alongi
Journal:  Clin Transl Oncol       Date:  2015-08-07       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.